194 related articles for article (PubMed ID: 7823026)
1. Biochemistry and molecular biology of the vesicular monoamine transporter from chromaffin granules.
Henry JP; Botton D; Sagne C; Isambert MF; Desnos C; Blanchard V; Raisman-Vozari R; Krejci E; Massoulie J; Gasnier B
J Exp Biol; 1994 Nov; 196():251-62. PubMed ID: 7823026
[TBL] [Abstract][Full Text] [Related]
2. The photoactivatable inhibitor 7-azido-8-iodoketanserin labels the N terminus of the vesicular monoamine transporter from bovine chromaffin granules.
Sagné C; Isambert MF; Vandekerckhove J; Henry JP; Gasnier B
Biochemistry; 1997 Mar; 36(11):3345-52. PubMed ID: 9116013
[TBL] [Abstract][Full Text] [Related]
3. Expression of a bovine vesicular monoamine transporter in COS cells.
Gasnier B; Krejci E; Botton D; Massoulié J; Henry JP
FEBS Lett; 1994 Apr; 342(3):225-9. PubMed ID: 8150075
[TBL] [Abstract][Full Text] [Related]
4. Cloning and functional expression of a tetrabenazine sensitive vesicular monoamine transporter from bovine chromaffin granules.
Howell M; Shirvan A; Stern-Bach Y; Steiner-Mordoch S; Strasser JE; Dean GE; Schuldiner S
FEBS Lett; 1994 Jan; 338(1):16-22. PubMed ID: 8307150
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of two vesicular monoamine transporters.
Peter D; Liu Y; Sternini C; de Giorgio R; Brecha N; Edwards RH
J Neurosci; 1995 Sep; 15(9):6179-88. PubMed ID: 7666200
[TBL] [Abstract][Full Text] [Related]
6. The vesicular monoamine transporter: from chromaffin granule to brain.
Henry JP; Sagné C; Bedet C; Gasnier B
Neurochem Int; 1998 Mar; 32(3):227-46. PubMed ID: 9587917
[TBL] [Abstract][Full Text] [Related]
7. Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.
Erickson JD; Schafer MK; Bonner TI; Eiden LE; Weihe E
Proc Natl Acad Sci U S A; 1996 May; 93(10):5166-71. PubMed ID: 8643547
[TBL] [Abstract][Full Text] [Related]
8. Expression and regulation of the bovine vesicular monoamine transporter gene.
Krejci E; Gasnier B; Botton D; Isambert MF; Sagné C; Gagnon J; Massoulié J; Henry JP
FEBS Lett; 1993 Nov; 335(1):27-32. PubMed ID: 7902299
[TBL] [Abstract][Full Text] [Related]
9. Reserpine- and tetrabenazine-sensitive transport of (3)H-histamine by the neuronal isoform of the vesicular monoamine transporter.
Erickson JD; Eiden LE; Schafer MK; Weihe E
J Mol Neurosci; 1995; 6(4):277-87. PubMed ID: 8860238
[TBL] [Abstract][Full Text] [Related]
10. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. II. Expression in neural crest derivatives and their target sites in the rat.
Hansson SR; Mezey E; Hoffman BJ
Brain Res Dev Brain Res; 1998 Sep; 110(1):159-74. PubMed ID: 9733958
[TBL] [Abstract][Full Text] [Related]
11. Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat.
Weihe E; Schäfer MK; Erickson JD; Eiden LE
J Mol Neurosci; 1994; 5(3):149-64. PubMed ID: 7654518
[TBL] [Abstract][Full Text] [Related]
12. Expression cloning of a reserpine-sensitive vesicular monoamine transporter.
Erickson JD; Eiden LE; Hoffman BJ
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10993-7. PubMed ID: 1438304
[TBL] [Abstract][Full Text] [Related]
13. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells.
Liu Y; Schweitzer ES; Nirenberg MJ; Pickel VM; Evans CJ; Edwards RH
J Cell Biol; 1994 Dec; 127(5):1419-33. PubMed ID: 7962100
[TBL] [Abstract][Full Text] [Related]
14. Vesicular monoamine transporter in microvesicles from bovine posterior pituitaries is immunologically similar to but distinct from the chromaffin granule counterpart in its sensitivities to 1-methyl-4-phenylpyridinium and histamine.
Moriyama Y; Yamada H
Biochem Biophys Res Commun; 1996 Apr; 221(3):790-4. PubMed ID: 8630040
[TBL] [Abstract][Full Text] [Related]
15. The catecholamine transporter of adrenal medulla chromaffin granules.
Henry JP; Gasnier B; Desnos C; Scherman D; Krejci E; Massoulié J
Ann N Y Acad Sci; 1994 Sep; 733():185-92. PubMed ID: 7978866
[No Abstract] [Full Text] [Related]
16. Individual residues contribute to multiple differences in ligand recognition between vesicular monoamine transporters 1 and 2.
Finn JP; Edwards RH
J Biol Chem; 1997 Jun; 272(26):16301-7. PubMed ID: 9195934
[TBL] [Abstract][Full Text] [Related]
17. Vesicular amine transporter expression and isoform selection in developing brain, peripheral nervous system and gut.
Schütz B; Schäfer MK; Eiden LE; Weihe E
Brain Res Dev Brain Res; 1998 Mar; 106(1-2):181-204. PubMed ID: 9555003
[TBL] [Abstract][Full Text] [Related]
18. Identification of residues involved in substrate recognition by a vesicular monoamine transporter.
Merickel A; Rosandich P; Peter D; Edwards RH
J Biol Chem; 1995 Oct; 270(43):25798-804. PubMed ID: 7592763
[TBL] [Abstract][Full Text] [Related]
19. The vesicular monoamine transporter 2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei.
Nirenberg MJ; Liu Y; Peter D; Edwards RH; Pickel VM
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8773-7. PubMed ID: 7568015
[TBL] [Abstract][Full Text] [Related]
20. Chimeric vesicular monoamine transporters identify structural domains that influence substrate affinity and sensitivity to tetrabenazine.
Peter D; Vu T; Edwards RH
J Biol Chem; 1996 Feb; 271(6):2979-86. PubMed ID: 8621690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
